Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride

We are Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride CAS:27668-52-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Chemical Name:Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride
CAS.NO:27668-52-6
Synonyms:3-(Trimethoxysilyl)propyldimethyloctodecyl-Ammonium Chloride;
N,N'-Dimethyl-N-Octodecyltrimethoxysilylpropyl-Ammonium Chloride;
N,N'-Dimethyl-N-(3-(Trimethoxysilyl)Propyl)Octadecyl-1-Aminonium Chloride;
Octadecyldimethyl(3-Trimethoxysilylpropyl)-Ammonium Chloride
Molecular Formula:C26H58ClNO3Si
Molecular Weight:496.28200
 
Physical and Chemical Properties:
Density:0.89;
Boiling point:68oC;
Flash point:15oC;
Index of Refraction:1.3889;
 
Specification:
Appearance:Colorless transparent liquid
Active Concentrate:40-60%
 
Packing:180 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is antimicrobial can impart durable biostatic activity to the surface of a wide variety of substrates. Durable bacteriostatic, fungistatic and algistatic surfaces can be attained with a minimum amount of it.
It is effective against mold, mildew and algae as a static agent.
It can provide freshness and combats deterioration and discoloration caused by bacteria, fungi and algae.

Dimethyloctadecyl[3-(trimethoxysilyl)propyl]ammonium chloride


Related News: The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.Pentafluorophenol The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.5-Chloropyridine-2-carbonitrile CAS:89809-64-3 The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.2,3-dimercaptobutano CAS:4532-64-3 “Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.

Related Products
Product Name
2,4,6-Triisopropylbenzenesulfonyl Azide View Details
(aR,bS)-rel-α-Hydroxy-β-[[(phenylmethoxy)carbonyl]amino]benzenebutanoic acid View Details
2-Chloro-5-fluoro-6-methylpyridine View Details
4,5-DIFLUORO-2-METHYLBENZOIC ACID manufacturer Pentyl chloroformate manufacturer Polyinosinic-polycytidylic acid sodium manufacturer 1-pyridin-2-ylpiperazine manufacturer 3-Bromo-2-pyridinecarboxylic acid manufacturer